Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Chromatin acetylation, a critical regulator of synaptic plasticity and memory processes, is thought to be altered in neurodegenerative diseases. Here, we demonstrate that spatial memory and plasticity (LTD, dendritic spine formation) deficits can be restored in a mouse model of tauopathy following treatment with CSP‐TTK21, a small‐molecule activator of CBP/p300 histone acetyltransferases (HAT). At the transcriptional level, CSP‐TTK21 re‐established half of the hippocampal transcriptome in learning mice, likely through increased expression of neuronal activity genes and memory enhancers. At the epigenomic level, the hippocampus of tauopathic mice showed a significant decrease in H2B but not H3K27 acetylation levels, both marks co‐localizing at TSS and CBP enhancers. Importantly, CSP‐TTK21 treatment increased H2B acetylation levels at decreased peaks, CBP enhancers, and TSS, including genes associated with plasticity and neuronal functions, overall providing a 95% rescue of the H2B acetylome in tauopathic mice. This study is the first to provide in vivo proof‐of‐concept evidence that CBP/p300 HAT activation efficiently reverses epigenetic, transcriptional, synaptic plasticity, and behavioral deficits associated with Alzheimer's disease lesions in mice. Epigenetic dysfunctions related to H2B histone acetylation were shown in the hippocampus of a mouse model of Alzheimer's disease. A therapeutic strategy aimed at activating CBP/p300 acetyltransferase revealed efficient at rescuing neuronal activity, plasticity and memory in these mice. Epigenetic dysfunctions related to H2B histone acetylation were shown in the hippocampus of a mouse model of Alzheimer's disease. A therapeutic strategy aimed at activating CBP/p300 acetyltransferase revealed efficient at rescuing neuronal activity, plasticity and memory in these mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · cited 1×
“Statistical analysis was performed with the method proposed by Love et al (2014) implemented in the DESeq2 Bioconductor library (v1.”
GREAT improves functional interpretation of cis-regulatory regions
McLean, C. Y., Bristor, D., Hiller, M., Clarke, S. L., Schaar, B. T., Lowe, C. B., Wenger, A. M., & Bejerano, G. (2010) · Nature Biotechnology · doi:10.1038/nbt.1630 · Cited by 4,502
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345 · cited 1×
“Alzheimer’s disease (AD) is characterized by the accumulation of amyloid beta peptides and abnormally phosphorylated Tau proteins, and a progressive impairment of plasticity and memory functions, ending in massive neuronal loss and dementia (Serrano-Pozo et al, 2011).”
BackgroundHyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092 · cited 1×
“One reason why most AD clinical studies may have failed is that cognitive dysfunctions associated with AD patients emerge late in the progression of the disease, when the brain is already affected by amyloid b deposition, neurofibrillary tangles, and cell death (Hyman et al, 2012).”
BackgroundWidespread transcription at neuronal activity-regulated enhancers
Kim, T.-K., Hemberg, M., Gray, J. M., Costa, A. M., Bear, D. M., Wu, J., Harmin, D. A., Laptewicz, M., Barbara-Haley, K., Kuersten, S., et al. (2010) · Nature · doi:10.1038/nature09033 · Cited by 2,450 · cited 5×
“CBP is a transcriptional co-activator of neuronal gene expression that acts through cAMP/CREB and calcium-dependent signaling (Hardingham et al, 1999; Kim et al, 2010).”
InfluentialSuppression of Aging in Mice by the Hormone Klotho
Kurosu, H., Yamamoto, M., Clark, J. D., Pastor, J. V., Nandi, A., Gurnani, P., McGuinness, O. P., Chikuda, H., Yamaguchi, M., Kawaguchi, H., et al. (2005) · Science · doi:10.1126/science.1112766 · Cited by 1,935
Chromatin Acetylation, Memory, and LTP Are Impaired in CBP+/− Mice
Alarcón, J. M., Malleret, G., Touzani, K., Vronskaya, S., Ishii, S., Kandel, E. R., & Barco, A. (2004) · Neuron · doi:10.1016/j.neuron.2004.05.021 · Cited by 892 · cited 3×
“…(Rouaux et al, 2003, 2004) and CBP/p300 HATs play important roles in neuronal plasticity and cognition, including hippocampal long-term potentiation (LTP) and long-term memory (Alarcon et al, 2004; Vecsey et al, 2007; Barrett et al, 2011; Valor et al, 2011; West & Greenberg, 2011).”
BackgroundJin, Q., Yu, L., Wang, L., Zhang, Z., Kasper, L. H., Lee, J., Wang, C., Brindle, P. K., Dent, S. Y. R., & Ge, K. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.318 · Cited by 877
An epigenetic blockade of cognitive functions in the neurodegenerating brain
Gräff, J., Rei, D., Guan, J.-S., Wang, W.-Y., Seo, J., Hennig, K. M., Nieland, T. J. F., Fass, D. M., Kao, P. F., Kahn, M., et al. (2012) · Nature · doi:10.1038/nature10849 · Cited by 853
Cited by
Alquezar, C., Arya, S., & Kao, A. W. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.595532 · Cited by 367
Chen, X., Li, Y., Wang, C., Tang, Y., Mok, S.-A., Tsai, R. M., Rojas, J. C., Karydas, A., Miller, B. L., Boxer, A. L., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0354-0 · Cited by 107
Li, T. Y., Sleiman, M. B., Li, H., Gao, A. W., Mottis, A., Bachmann, A. M., Alam, G. E., Li, X., Goeminne, L. J. E., Schoonjans, K., et al. (2021) · Nature Aging · doi:10.1038/s43587-020-00025-z · Cited by 78
Cognitive epigenetic priming: leveraging histone acetylation for memory amelioration
Burns, A. M., & Gräff, J. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.08.011 · Cited by 62
“For example, activating the HAT CBP/p300 using the HAT activator CSP-TTK21, reinstated levels of H2B acetylation, rescued transcription of genes involved in ion transport and learning and restored spatial memory in a mouse model for tauopathy, THY-Tau22 [47].”
Small molecule modulators of chromatin remodeling: from neurodevelopment to neurodegeneration
Jiang, D., Li, T., Guo, C., Tang, T.-S., & Liu, H. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-00953-4 · Cited by 54
Metadata
- Authors
- Chatterjee, S., Cassel, R., Schneider‐Anthony, A., Merienne, K., Cosquer, B., Tzeplaeff, L., Halder Sinha, S., Kumar, M., Chaturbedy, P., Eswaramoorthy, M., Le Gras, S., Keime, C., Bousiges, O., Dutar, P., Petsophonsakul, P., Rampon, C., Cassel, J., Buée, L., Blum, D., Kundu, T. K., & Boutillier, A.
- Venue
- EMBO Molecular Medicine
- Published
- 2018-10
- Volume
- 10
- Issue
- 11
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W2894821853
- Cited by
- 99
- References
- 24
- FWCI
- 7.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator. https://app.cochat.ai/papers/10.15252/emmm.201708587
- The paper
- Chatterjee, S., Cassel, R., Schneider‐Anthony, A., Merienne, K., Cosquer, B., Tzeplaeff, L., Halder Sinha, S., Kumar, M., Chaturbedy, P., Eswaramoorthy, M., Le Gras, S., Keime, C., Bousiges, O., Dutar, P., Petsophonsakul, P., Rampon, C., Cassel, J., Buée, L., Blum, D., . . . Boutillier, A. (2018). Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator. EMBO Molecular Medicine. https://doi.org/10.15252/emmm.201708587
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.